AURKA and glioblastoma: Aur-A and/or Aur-B overexpression has been reported in multiple types of tumors, including NSCLC, thyroid, breast, colon, pancreatic, ovarian, gastric, prostate, and glioblastoma, and contributed to tumor grade and prognosis [17–28].